Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.
To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with DHA
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).
Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).
Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Portillo-Reyes V et al. | Clinical significance of neuropsychological improvement after supplementation with omega-3 in 8-12 years old malnourished Mexican children: a randomized, double-blind, placebo and treatment clinical trial. | 2014 | Res Dev Disabil | pmid:24508294 |
Hirafuji M et al. | Effect of docosahexaenoic acid on intracellular calcium dynamics in vascular smooth muscle cells from normotensive and genetically hypertensive rats. | 1998 | Res. Commun. Mol. Pathol. Pharmacol. | pmid:9920344 |
Kimura S et al. | Docosahexaenoic acid inhibits blood viscosity in stroke-prone spontaneously hypertensive rats. | 1998 | Res. Commun. Mol. Pathol. Pharmacol. | pmid:9730013 |
Kimura S et al. | Ameliorative effects of docosahexaenoic acid on serum lipid changes in stroke-prone spontaneously hypertensive rats. | 1998 | Res. Commun. Mol. Pathol. Pharmacol. | pmid:9644719 |
Lecchi C et al. | Effects of EPA and DHA on lipid droplet accumulation and mRNA abundance of PAT proteins in caprine monocytes. | 2013 | Res. Vet. Sci. | pmid:23102647 |
Nordgren TM et al. | Maresin-1 reduces the pro-inflammatory response of bronchial epithelial cells to organic dust. | 2013 | Respir. Res. | pmid:23663457 |
Liao Z et al. | Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. | 2012 | Respir. Res. | pmid:23199346 |
Aarsetøy H et al. | Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction. | 2008 | Resuscitation | pmid:18556107 |
Birch DG | A randomized placebo-controlled clinical trial of docosahexaenoic acid (DHA) supplementation for X-linked retinitis pigmentosa. | 2005 | Retina (Philadelphia, Pa.) | pmid:16374336 |
Spaide RF et al. | Characterization of peroxidized lipids in Bruch's membrane. | 1999 | Retina (Philadelphia, Pa.) | pmid:10213241 |
Gustavsson C et al. | Inflammatory markers in nondiabetic and diabetic rat retinas exposed to ischemia followed by reperfusion. | 2008 | Retina (Philadelphia, Pa.) | pmid:18398369 |
Valenzuela A and Nieto MS | [Docosahexaenoic acid (DHA) in fetal development and in infant nutrition]. | 2001 | Rev Med Chil | pmid:11775350 |
Leon MM et al. | [Resolution of inflammation--pharmacological aspects]. | 2011 Apr-Jun | Rev Med Chir Soc Med Nat Iasi | pmid:21870743 |
López-Alarcón M et al. | [The effect of docosahexaenoic acid on the loss of appetite in pediatric patients with pneumonia]. | 2006 Jan-Feb | Rev Med Inst Mex Seguro Soc | pmid:16497254 |
Maillard MH | [Resolvins: new derivates of fatty acids, polyunsaturated (omega-3) with therapeutic potential in inflammatory intestinal diseases]. | 2006 | Rev Med Suisse | pmid:17343155 |
Gutiérrez-Mata AP et al. | [Neurological, neuropsychological, and ophthalmological evolution after one year of docosahexaenoic acid supplementation in phenylketonuric patients]. | 2012 | Rev Neurol | pmid:22829083 |
MartÃnez M et al. | [Treatment of generalized peroxisomal disorders with docosahexaenoic acid ethyl ether]. | 1999 | Rev Neurol | pmid:10778491 |
Carratalá-Marco F et al. | [The influence of docosahexaenoic acid and moderate perinatal hypoxia on the performance of one-month-old Wistar rats in a T-maze test]. | 2010 | Rev Neurol | pmid:20669126 |
Wright AK et al. | Slowly progressive dopamine cell loss--a model on which to test neuroprotective strategies for Parkinson's disease? | 2009 | Rev Neurosci | pmid:19774787 |
Torres AG and Trugo NM | Evidence of inadequate docosahexaenoic acid status in Brazilian pregnant and lactating women. | 2009 | Rev Saude Publica | pmid:19287877 |